euro-biopharma-ethnopharmacology-2017-posters

Volume 6, Issue 4 (Suppl)

Clin Pharmacol Biopharm, an open access journal

ISSN: 2167-065X

Page 90

Euro Biopharma & Ethnopharmacology 2017

November 09-11, 2017

International Conference and Exhibition on

November 09-11, 2017 Vienna, Austria

EUROPEAN BIOPHARMA CONGRESS

PHARMACOLOGY AND ETHNOPHARMACOLOGY

Joint Event

Medicaments and pregnancy

Tomo Igor

Raganová Andrea, Kriška Milan

, Bartekova Katarina

and

Bohmer Daniel

University in Bratislava, Slovakia

rugs administered during pregnancy there are in interest of professionals as they could influence embryogenesis.

These can have temporary or permanent effects on the fetus development. Any drug with relation a dose can act during

embryonic or fetal development to produce a permanent alteration of form or function. Study this problems in the territory of

Slovakia our retrospective study was performed between May 2016 and November 2016. Amethod of questioning concerning

pregnant women about their drug consumption. The examined group consisted of 300 women becoming from region of

Bratislava. The data recovered from questionnaire were obtained up to 4 days after delivery. The data were statistically analysed.

Based on the results of this study no statistically significant correlation was found between drug intake during pregnancy and

increase in prevalence of the congenital malformations in the group. However the causal coincidence between drug intake

and congenital disorder is rather difficult to establish. The number of drug consuments in the region of Bratislava reached

88%. That includes also a group of consuments of supplements. Women that consumed vitamins, minerals and Fe form 49%

of all examined women. Pregnant women which used vitamins during the first trimester were 32% of all. The group of women

that used Fe in the third trimester was 40% of all examined women. The most frequently used drugs except supplements were

hormones in 11%, anticoagulants in 7% and antibiotics in 5%. Similar studies with pregnant women performed in the U.S.A.

or in Western Europe have shown higher exposition levels of the prescription drugs. The choice of drugs used in different

countries is also quite specific, which makes extrapolation between countries rather difficult. The drug registration process,

prescription customs, drug availability etc. also needs to be taken in consideration.

Clin Pharmacol Biopharm 2017, 6:4(Suppl)

DOI: 10.4172/2167-065X-C1-026